At the same time, though primary AML and MDS do share similar gene aberrations, there are also plenty of differences, such as MDS cells needing additional genetic mutations in order to develop into AML blasts (mutations in RUNX1, NRAS, and NTRK3) [7]. Here, RUNX1 is linked to acute myeloid leukemia.